Angel J. De La Rosa

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Bioengineering approaches to dynamic impact analysis for cranial fracture interpretation in arcaheology.

Bioengineering approaches to dynamic impact analysis for cranial fracture interpretation in arcaheology.

Journal: Scientific reports

Published: August 28, 2025

Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.

Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.

Journal: Journal of cellular physiology

Published: February 04, 2024

Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.

Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.

Journal: Journal of cellular physiology

Published: January 29, 2018

Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.

Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.

Journal: PloS one

Published: February 14, 2017

Nitric Oxide Synthase Type III Overexpression By Gene Therapy Exerts Antitumoral Activity In Mouse Hepatocellular Carcinoma.

Nitric Oxide Synthase Type III Overexpression By Gene Therapy Exerts Antitumoral Activity In Mouse Hepatocellular Carcinoma.

Journal: Redox biology

Published: August 01, 2015

CD95 signaling in cancer treatment.

CD95 signaling in cancer treatment.

Journal: Current pharmaceutical design

Published: June 08, 2013

Nitric oxide and cell death in liver cancer cells.

Nitric oxide and cell death in liver cancer cells.

Journal: Mitochondrion

Published: May 25, 2012

Targeting tyrosine kinase receptors in hepatocellular carcinoma.

Targeting tyrosine kinase receptors in hepatocellular carcinoma.

Journal: Current cancer drug targets

Published: January 04, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026